Epstein-Barr virus-associated T cell lymphoproliferative disorder following autologous blood stem cell transplantation for relapsed Hodgkin's disease

Bone Marrow Transplant. 2000 Dec;26(12):1339-41. doi: 10.1038/sj.bmt.1702721.

Abstract

Post-transplant lymphoproliferative disorders (PTLD) of T cell type are a rare complication of solid organ and allogeneic hematopoietic cell transplantation (HCT), and usually are not associated with Epstein-Barr virus (EBV) infection. EBV-associated T cell PTLD has not been reported to occur after autologous HCT. We report an unusual case of T cell lymphoproliferation after autologous blood stem cell transplantation (ABSCT). A patient with relapsed Hodgkin's disease developed abdominal lymphadenopathy followed by atypical CD8+ lymphocytosis in the peripheral blood 30 months following ABSCT. DNA studies of the atypical lymphocytes demonstrated rearrangements of the T cell receptor beta gene and a clonal proliferation of EBV.

Publication types

  • Case Reports

MeSH terms

  • Clone Cells / pathology
  • Clone Cells / virology
  • DNA, Viral
  • Epstein-Barr Virus Infections / complications*
  • Hematopoietic Stem Cell Transplantation / adverse effects
  • Hodgkin Disease / complications
  • Hodgkin Disease / therapy*
  • Humans
  • Lymphoproliferative Disorders / complications
  • Lymphoproliferative Disorders / virology*
  • Male
  • Middle Aged
  • Recurrence
  • Transplantation, Autologous / adverse effects*

Substances

  • DNA, Viral